 | • レポートコード：MRC2302F0130 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、247ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に287.46百万ドルであった世界の生細胞カプセル化市場規模が、2022年に299.44百万ドルになり、2027年まで年平均4.34%で成長して371.02百万ドルまで拡大すると予測しています。本レポートは、生細胞カプセル化の世界市場について調査し、市場の動向を明らかにした資料であり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製造技術別（同軸気流、静電ドリッピング、ジェットカット、リキッドジェットブレイクアップ、その他）分析、ポリマー種類別（アルギン酸塩、セルロースサルフェート、キトサン、Hema-メチルメタクリレート）分析、用途別（細胞移植、薬物送達、プロバイオティクス、再生医療、研究）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など以下の構成でまとめています。また、Altucell, Inc.、Beta-O2 Technologies Ltd、Biotime, Inc.、Blacktrace Group、Büchi Labortechnik AG、Defymed、Evonik Industries、Gloriana Therapeutics、Kadimastem、Living Cell Technologies、Neurotech Holdings, LLC.、Pharmacyte Biotech, Inc.、Sernova Corporation、Sigilon Therapeutics、Viacyte, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の生細胞カプセル化市場規模：製造技術別 - 同軸気流における市場規模 - 静電ドリッピングにおける市場規模 - ジェットカットにおける市場規模 - リキッドジェットブレイクアップにおける市場規模 - その他における市場規模 ・世界の生細胞カプセル化市場規模：ポリマー種類別 - アルギン酸塩の市場規模 - セルロースサルフェートの市場規模 - キトサンの市場規模 - Hema-メチルメタクリレートの市場規模 ・世界の生細胞カプセル化市場規模：用途別 - 細胞移植における市場規模 - 薬物送達における市場規模 - プロバイオティクスにおける市場規模 - 再生医療における市場規模 - 研究における市場規模 ・世界の生細胞カプセル化市場規模：地域別 - 南北アメリカの生細胞カプセル化市場規模 アメリカの生細胞カプセル化市場規模 カナダの生細胞カプセル化市場規模 ブラジルの生細胞カプセル化市場規模 … - アジア太平洋の生細胞カプセル化市場規模 日本の生細胞カプセル化市場規模 中国の生細胞カプセル化市場規模 インドの生細胞カプセル化市場規模 韓国の生細胞カプセル化市場規模 台湾の生細胞カプセル化市場規模 … - ヨーロッパ/中東/アフリカの生細胞カプセル化市場規模 イギリスの生細胞カプセル化市場規模 ドイツの生細胞カプセル化市場規模 フランスの生細胞カプセル化市場規模 ロシアの生細胞カプセル化市場規模 … - その他地域の生細胞カプセル化市場規模 ・競争状況 ・企業情報 |
The Global Live Cell Encapsulation Market size was estimated at USD 287.46 million in 2021 and expected to reach USD 299.44 million in 2022, and is projected to grow at a CAGR 4.34% to reach USD 371.02 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Live Cell Encapsulation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Manufacturing Techniques, the market was studied across Coaxial Airflow, Electrostatic Dripping, Jet Cutting, Liquid-Jet Break-Up, Rotating Disk Atomization, Simple Dripping, and Vibrating-Jet Technique.
Based on Polymer Type, the market was studied across Alginate, Cellulose Sulfate, Chitosan, Hema-Mma, PAN-PVC, and Siliceous Encapsulates.
Based on Application, the market was studied across Cell Transplantation, Drug Delivery, Probiotics, Regenerative Medicine, and Research.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Live Cell Encapsulation market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Live Cell Encapsulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Live Cell Encapsulation Market, including Altucell, Inc., Beta-O2 Technologies Ltd, Biotime, Inc., Blacktrace Group, Büchi Labortechnik AG, Defymed, Evonik Industries, Gloriana Therapeutics, Kadimastem, Living Cell Technologies, Neurotech Holdings, LLC., Pharmacyte Biotech, Inc., Sernova Corporation, Sigilon Therapeutics, and Viacyte, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Live Cell Encapsulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Live Cell Encapsulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Live Cell Encapsulation Market?
4. What is the competitive strategic window for opportunities in the Global Live Cell Encapsulation Market?
5. What are the technology trends and regulatory frameworks in the Global Live Cell Encapsulation Market?
6. What is the market share of the leading vendors in the Global Live Cell Encapsulation Market?
7. What modes and strategic moves are considered suitable for entering the Global Live Cell Encapsulation Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
5.1.1.2. Increasing investment via public-private investments to support the Novel product development coupled with technology advancements
5.1.1.3. Public awareness related to the clinical role of encapsulated cells in disease management
5.1.2. Restraints
5.1.2.1. Limited availability of quality raw material
5.1.2.2. High production cost
5.1.3. Opportunities
5.1.3.1. Focus on Novel drug delivery systems
5.1.3.2. Ongoing research activities
5.1.4. Challenges
5.1.4.1. Availability and adoption of alternative therapies
5.2. Cumulative Impact of COVID-19
6. Live Cell Encapsulation Market, by Manufacturing Techniques
6.1. Introduction
6.2. Coaxial Airflow
6.3. Electrostatic Dripping
6.4. Jet Cutting
6.5. Liquid-Jet Break-Up
6.6. Rotating Disk Atomization
6.7. Simple Dripping
6.8. Vibrating-Jet Technique
7. Live Cell Encapsulation Market, by Polymer Type
7.1. Introduction
7.2. Alginate
7.3. Cellulose Sulfate
7.4. Chitosan
7.5. Hema-Mma
7.6. PAN-PVC
7.7. Siliceous Encapsulates
8. Live Cell Encapsulation Market, by Application
8.1. Introduction
8.2. Cell Transplantation
8.3. Drug Delivery
8.4. Probiotics
8.5. Regenerative Medicine
8.6. Research
9. Americas Live Cell Encapsulation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Live Cell Encapsulation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Live Cell Encapsulation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Altucell, Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Beta-O2 Technologies Ltd
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Biotime, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Blacktrace Group
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Büchi Labortechnik AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Defymed
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Evonik Industries
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Gloriana Therapeutics
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Kadimastem
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Living Cell Technologies
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Neurotech Holdings, LLC.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Pharmacyte Biotech, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Sernova Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Sigilon Therapeutics
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Viacyte, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing